Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Ashley

Showing results (71-80 of 128) with videos related to

Pageof 13
Sort By:
Neuro-Oncology Advances|May 30, 2024
A neural tract-inspired conduit for facile, on-demand biopsy of glioblastomaMartha I Betancur, Ayden Case, Ekaterina Ilich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2023
A Pilot Study Omitting Radiation in the Treatment of Children with Newly Diagnosed Wnt-Activated MedulloblastomaKenneth J Cohen, Vasu Munjapara, Dolly Aguilera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2016
Low-Dose Histone Deacetylase Inhibitor Treatment Leads to Tumor Growth Arrest and Multi-Lineage Differentiation of Malignant Rhabdoid TumorsAndrea Muscat, Dean Popovski, W Samantha N Jayasekara, et al.
Journal of Neuro-Oncology|March 7, 2020
Patterns of relapse after successful completion of initial therapy in primary central nervous system lymphoma: a case seriesMallika P Patel, John P Kirkpatrick, Margaret O Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Neurocognitive consequences of risk-adapted therapy for childhood medulloblastomaRaymond K Mulhern, Shawna L Palmer, Thomas E Merchant, et al.
Epigenetics|January 8, 2014
Epigenetic deregulation in pediatric acute lymphoblastic leukemiaZac Chatterton, Leah Morenos, Francoise Mechinaud, et al.
Neuro-Oncology Practice|March 18, 2024
Use, access, and initial outcomes of off-label ivosidenib in patients with IDH1 mutant gliomaKatherine B Peters, Candice Alford, Amy Heltemes, et al.
Complementary Therapies in Clinical Practice|August 7, 2019
Complementary and integrative health interventions and their association with health-related quality of life in the primary brain tumor populationDina M Randazzo, Frances McSherry, James E Herndon, et al.
CNS Oncology|September 21, 2021
Primary brain tumor patients admitted to a US intensive care unit: a descriptive analysisJennifer H Kang, Christa B Swisher, Evan D Buckley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2006
Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterationsMargaret C Thompson, Christine Fuller, Twala L Hogg, et al.
Pageof 13

Showing results (71-80 of 128) with videos related to

Sort By:
Pageof 13
Neuro-Oncology Advances|May 30, 2024
A neural tract-inspired conduit for facile, on-demand biopsy of glioblastomaMartha I Betancur, Ayden Case, Ekaterina Ilich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2023
A Pilot Study Omitting Radiation in the Treatment of Children with Newly Diagnosed Wnt-Activated MedulloblastomaKenneth J Cohen, Vasu Munjapara, Dolly Aguilera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2016
Low-Dose Histone Deacetylase Inhibitor Treatment Leads to Tumor Growth Arrest and Multi-Lineage Differentiation of Malignant Rhabdoid TumorsAndrea Muscat, Dean Popovski, W Samantha N Jayasekara, et al.
Journal of Neuro-Oncology|March 7, 2020
Patterns of relapse after successful completion of initial therapy in primary central nervous system lymphoma: a case seriesMallika P Patel, John P Kirkpatrick, Margaret O Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Neurocognitive consequences of risk-adapted therapy for childhood medulloblastomaRaymond K Mulhern, Shawna L Palmer, Thomas E Merchant, et al.
Epigenetics|January 8, 2014
Epigenetic deregulation in pediatric acute lymphoblastic leukemiaZac Chatterton, Leah Morenos, Francoise Mechinaud, et al.
Neuro-Oncology Practice|March 18, 2024
Use, access, and initial outcomes of off-label ivosidenib in patients with IDH1 mutant gliomaKatherine B Peters, Candice Alford, Amy Heltemes, et al.
Complementary Therapies in Clinical Practice|August 7, 2019
Complementary and integrative health interventions and their association with health-related quality of life in the primary brain tumor populationDina M Randazzo, Frances McSherry, James E Herndon, et al.
CNS Oncology|September 21, 2021
Primary brain tumor patients admitted to a US intensive care unit: a descriptive analysisJennifer H Kang, Christa B Swisher, Evan D Buckley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2006
Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterationsMargaret C Thompson, Christine Fuller, Twala L Hogg, et al.
Pageof 13